1
Comparative Bioavailability – Gender Effect – Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505
Condition(s):Type 2 Diabetes; Diabetes Mellitus, Type 2; Metabolic Diseases; Cardiovascular Diseases; Obese; DyslipidemiaLast Updated:November 27, 2012Completed